Home » Topics » Regulatory

Regulatory
RSS

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

FDA approves new dosing regimen for SB's amoxicillin

July 27, 1998

Zelapar receives approval recommendation in U.K.

July 23, 1998

FDA approves new dose range for Zocor

July 23, 1998

Vigabatrin is effective for treating alcohol withdrawal syndrome

July 22, 1998

Analgesic effects of dosulepin in patients with cancer-related pain

July 22, 1998

New indication explored for established anticonvulsant

July 21, 1998

Celgene cleared to market Thalomid in U.S.

July 20, 1998

One-year trial shows efficacy of lamivudine for treatment for chronic hepatitis B

July 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...